ALT-L9 (aflibercept biosimilar) - Alteogen
Visudyne (verteporfin) - Novartis
Byooviz (ranibizumab biosimilar) - Samsung, AffaMed Therap, Biogen
Krabeva (bevacizumab biosimilar) - Viatris, Biocon
Xlucane (ranibizumab biosimilar) - Stada, Xbrane, Helvetic
FYB203 (aflibercept biosimilar) - Amneal
Susvimo (ranibizumab port delivery system) - Roche
FYB201 (ranibizumab biosimilar) - Amneal, Formycon, Coherus Biosci, Teva
iridescimab vidros (KSI 301) - Kodiak Sciences
M710 (aflibercept biosimilar) - Viatris, J&J
Eylea (aflibercept intravitreal) - Bayer, Regeneron
PF582 (ranibizumab biosimilar) - Ligand
CHS-2020 (aflibercept biosimilar) - Coherus Biosci
Rayoqta (abicipar pegol) - Molecular Partners
SB15 (aflibercept biosimilar) - AffaMed Therap, Biogen, Samsung
OPT-302 - Opthea
Terifrac (teriparatide biosimilar) - Intas
Lucentis (ranibizumab) - Roche, Novartis
Razumab (ranibizumab biosimilar) - Intas
Lumitin (conbercept) - Chengdu Kanghong Biotech
http://www.ncbi.nlm.nih.gov/pubmed/34598731
 
Oct 3, 2021
 
Prev Next